Premier Shares Outstanding 2012-2025 | PINC
Premier shares outstanding from 2012 to 2025. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
| Premier Annual Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2024 | 114 |
| 2023 | 120 |
| 2022 | 122 |
| 2021 | 118 |
| 2020 | 124 |
| 2019 | 60 |
| 2018 | 137 |
| 2017 | 50 |
| 2016 | 145 |
| 2015 | 36 |
| 2014 | 26 |
| 2013 | 6 |
| 2012 | 6 |
| 2011 | 6 |
| Premier Quarterly Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2025-03-31 | 88 |
| 2024-12-31 | 95 |
| 2024-09-30 | 101 |
| 2024-06-30 | 114 |
| 2024-03-31 | 111 |
| 2023-12-31 | 120 |
| 2023-09-30 | 120 |
| 2023-06-30 | 120 |
| 2023-03-31 | 120 |
| 2022-12-31 | 120 |
| 2022-09-30 | 120 |
| 2022-06-30 | 122 |
| 2022-03-31 | 120 |
| 2021-12-31 | 122 |
| 2021-09-30 | 125 |
| 2021-06-30 | 118 |
| 2021-03-31 | 123 |
| 2020-12-31 | 123 |
| 2020-09-30 | 100 |
| 2020-06-30 | 124 |
| 2020-03-31 | 122 |
| 2019-12-31 | 65 |
| 2019-09-30 | 127 |
| 2019-06-30 | 62 |
| 2019-03-31 | 129 |
| 2018-12-31 | 134 |
| 2018-09-30 | 53 |
| 2018-06-30 | 137 |
| 2018-03-31 | 54 |
| 2017-12-31 | 139 |
| 2017-09-30 | 140 |
| 2017-06-30 | 50 |
| 2017-03-31 | 51 |
| 2016-12-31 | 141 |
| 2016-09-30 | 143 |
| 2016-06-30 | 145 |
| 2016-03-31 | 145 |
| 2015-12-31 | 42 |
| 2015-09-30 | 146 |
| 2015-06-30 | 36 |
| 2015-03-31 | 37 |
| 2014-12-31 | 36 |
| 2014-09-30 | 32 |
| 2014-06-30 | 26 |
| 2014-03-31 | 33 |
| 2013-12-31 | 32 |
| 2013-09-30 | 6 |
| 2013-06-30 | 6 |
| 2013-03-31 | 6 |
| 2012-12-31 | 6 |
| 2012-09-30 | 6 |
| 2012-06-30 | |
| 2011-06-30 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $1.779B | $1.346B |
| Premier, Inc. operates as a healthcare alliance. The company brings together hospitals, health systems, physicians and other healthcare providers primarily in the United States. It also maintains clinical, financial and outcomes databases. Premier, Inc. is headquartered in Charlotte, North Carolina. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $142.275B | 26.68 |
| CVS Health (CVS) | United States | $86.641B | 10.77 |
| Elevance Health (ELV) | United States | $86.192B | 11.12 |
| Cencora (COR) | United States | $58.034B | 20.19 |
| DiDi Global (DIDIY) | China | $23.015B | 24.45 |
| Natera (NTRA) | United States | $22.934B | 0.00 |
| Labcorp Holdings (LH) | United States | $21.811B | 17.69 |
| BioMerieux (BMXMF) | France | $16.861B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $13.798B | 0.00 |
| Solventum (SOLV) | United States | $13.056B | 13.82 |
| CochLear (CHEOY) | Australia | $12.649B | 0.00 |
| ICON (ICLR) | Ireland | $11.674B | 10.85 |
| Revvity (RVTY) | United States | $11.530B | 19.84 |
| Viatris (VTRS) | United States | $10.575B | 3.63 |
| Avantor (AVTR) | United States | $9.220B | 13.40 |
| HealthEquity (HQY) | United States | $9.070B | 39.73 |
| Medpace Holdings (MEDP) | United States | $8.930B | 23.72 |
| Sonic Healthcare (SKHHY) | Australia | $8.455B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.368B | 14.44 |
| Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
| Bausch + Lomb (BLCO) | Canada | $4.386B | 25.83 |
| BrightSpring Health Services (BTSG) | United States | $4.138B | 37.97 |
| Sotera Health (SHC) | United States | $3.213B | 18.26 |
| Surgery Partners (SGRY) | United States | $2.813B | 36.58 |
| Alignment Healthcare (ALHC) | United States | $2.740B | 0.00 |
| Concentras Parent (CON) | United States | $2.711B | 15.67 |
| GeneDx Holdings (WGS) | United States | $2.599B | 100.11 |
| Organon (OGN) | United States | $2.563B | 2.72 |
| PACS (PACS) | United States | $1.980B | 0.00 |
| Ardent Health (ARDT) | United States | $1.957B | 8.34 |
| Progyny (PGNY) | United States | $1.878B | 41.34 |
| GoodRx Holdings (GDRX) | United States | $1.750B | 35.00 |
| Teladoc Health (TDOC) | United States | $1.475B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.205B | 9.17 |
| Establishment Labs Holdings (ESTA) | $1.184B | 0.00 | |
| CareDx (CDNA) | United States | $1.071B | 16.72 |
| Agilon Health (AGL) | United States | $0.956B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $0.919B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.840B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.799B | 7.48 |
| Nutex Health (NUTX) | United States | $0.683B | 10.34 |
| LifeMD (LFMD) | United States | $0.625B | 0.00 |
| Embecta (EMBC) | United States | $0.563B | 3.80 |
| InnovAge Holding (INNV) | United States | $0.529B | 0.00 |
| Enhabit (EHAB) | United States | $0.484B | 39.83 |
| SBC Medicals (SBC) | United States | $0.481B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.475B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.469B | 10.57 |
| Omada Health (OMDA) | $0.453B | 0.00 | |
| Performant Healthcare (PHLT) | United States | $0.313B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.259B | 0.00 |
| Beauty Health (SKIN) | United States | $0.246B | 0.00 |
| So-Young (SY) | China | $0.240B | 0.00 |
| Oncology Institute (TOI) | United States | $0.195B | 0.00 |
| DocGo (DCGO) | United States | $0.163B | 26.67 |
| Sera Prognostics (SERA) | United States | $0.154B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.120B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.092B | 0.00 |
| KindlyMD (NAKA) | United States | $0.086B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.063B | 0.00 |
| NeueHealth (NEUE) | United States | $0.062B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.056B | 0.00 |
| ModivCare (MODV) | United States | $0.049B | 0.00 |
| Biodesix (BDSX) | United States | $0.037B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.034B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.032B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.011B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.002B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |